SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
57 hedge funds and large institutions have $240M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
-12
Holders Change %
-17.39%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
7
Increased
27
Reduced
10
Closed
19
Calls
$332K
Puts
$111K
Net Calls
+$221K
Net Calls Change
+$460K
Top Buyers
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$13.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$11.5M |
| 3 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$8.7M |
| 4 |
BlackRock
New York
|
+$4.6M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.37M |
Top Sellers
| 1 |
AC
Aisling Capital
New York
|
-$4.95M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.88M |
| 3 |
CC
Casdin Capital
New York
|
-$2.67M |
| 4 |
AIC
AWM Investment Company
New York
|
-$632K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$330K |
